Reactivity of the 1,3-beta-D-glucan assay during bacteraemia: limited evidence from a prospective study

Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216224%3A14110%2F13%3A00067409" target="_blank" >RIV/00216224:14110/13:00067409 - isvavai.cz</a>
Alternative codes found
RIV/65269705:_____/13:#0002194
Result on the web
<a href="http://dx.doi.org/10.1111/j.1439-0507.2012.02210.x" target="_blank" >http://dx.doi.org/10.1111/j.1439-0507.2012.02210.x</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1111/j.1439-0507.2012.02210.x" target="_blank" >10.1111/j.1439-0507.2012.02210.x</a>

Result language
angličtina
Original language name
Reactivity of the 1,3-beta-D-glucan assay during bacteraemia: limited evidence from a prospective study
Original language description
There are discrepancies in the retrospective studies published in literature of whether or not bacteraemia could lead to false positivity of 1,3betaD (BG) glucan assay. We performed, for the first time, a prospective study evaluating the role of bacterial bloodstream infection to the reactivity of BG assay. 26 episodes of bacteraemia that occurred in highrisk haematological patients were included in our study. Consecutive BG levels >80 pg/ml were required for test positivity. Only 2 of 26 patients were BG positive, both with IFDs. Thus, we prospectively did not prove bacteraemia as the source of cross reactivity of BG assay in haematological patients.
Czech name
—
Czech description
—

Type
J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)
CEP classification
FD - Oncology and haematology
OECD FORD branch
—

Project
Result was created during the realization of more than one project. More information in the Projects tab.
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Publication year
2013
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Similar results(10)